Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis

Fig. 3

a Healthcare resource utilization PPPY during the study period - treatment cohort-level [1]. Data on HCRU are presented for the cohorts that each comprised more than 5% of the analysis sub-sample (decided a priori) [2]. A total number of 14.5 days with medical visits per year in the discontinuation cohort indicates that there was an average of one visit per month, approximately (this interpretation applies across cohorts) [3]. Mean follow-up was 49.6 months in the discontinuation cohort, 49.1 months in the dose escalation cohort, and 50.6 months in the switch cohort [4]. Percentage within each bar represents proportion of days with mental health-related medical visits. b Total healthcare costs PPPY during the study period - treatment cohort-level [1]. Data on costs are presented for the cohorts that each comprised more than 5% of the analysis sub-sample (decided a priori) [2]. Mean follow-up was 49.6 months in the discontinuation cohort, 49.1 months in the dose escalation cohort, and 50.6 months in the switch cohort [3]. Percentages within each bar represent proportions of mental health-related medical costs and MDD-related pharmacy costs

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us